Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents

References

• McGinnis MR, Fader RC. Mycetoma: A contemporary con-cept. Infect Dis Clin North Am 1988; 2: 939–954.
   PubMedGoogle Scholar
• Fader RC, McGinnis MR. Infections caused by black fungi: Chromoblastomycosis and phaeohyphomycosis. Infect Dis Gun North Am 1988; 2: 925–938.
   PubMedGoogle Scholar
• Espinel-Ingroff A, Bartlett M, Bowden R, et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Gun Microbiol 1997; 35: 139–143.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of yeasts; reference standard. NCCLS document M27-A. Vil-lanova, PA: National Committee for Clinical Laboratory Stan-dards, 1997.
   Google Scholar
• Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997; 24: 369–374.
   PubMedGoogle Scholar
• Sughayer M, DeGirolami PC, Khettry U, et al. Human infec-tion caused by Exophiala pisciphila: case report and review. Rev Infect Dis 1991; 13: 379–382.
   PubMedGoogle Scholar
• Hachisuka H, Matsumoto T, Kusuhara M, Nomura H, Nakano S, Sasai Y. Cutaneous phaeohyphomycosis caused by Exophiala jeanselmei after renal transplantation. Int J Denn 1990; 29: 198–200.
   Google Scholar
• Rinaldi MG, Ramsey KM, Washington JM, Gatson AM, Buck GE. Recurrent Exophiala spinifera diagnosed in a patient with renal allograft. Mycol Observ 1987; 7: 1–4.
   Google Scholar
• Ronan SG, Uzoaru I, Nadimpalli V, Guitart J, Manaligod JR. Primary cutaneous phaeohyphomycosis: report of seven cases. J Cutan Pathol 1993; 20: 223–228.
   PubMedGoogle Scholar
• Sindhuphak W, MacDonald E, Head E, Hudson RD. Ex - ophiala jeanselmei infection in a postrenal transplant patient. J Am Acad Dermatol 1985; 13: 877–881.
   PubMedGoogle Scholar
• Wackym PA, Gray Jr GF, Richie RE, Gregg CR. Cutaneous chromomycosis in renal transplant recipients. Successful man-agement in two cases. Arch Intern Med 1985; 145: 1036–1037.
   PubMedGoogle Scholar
• Pedersen NB, Mardh PA, Hallberg T, Johnson N. Cutaneous alternariosis. Br J Dermatol 1967; 94: 201–209.
   Google Scholar
• Bourlond A, Alexandre G. Dermal alternariasis in a kidney transplant recipient. Dermatologica 1984; 168: 152–156.
   PubMedGoogle Scholar
• Fincher RM, Fisher JF, Padhye AA, Ajello L, Steele Jr JC. Subcutaneous phaeohyphomycotic abscess caused by Phialophora parasitica in a renal allograft recipient. J Med Vet Mycol 1988; 26: 311–314.
   Google Scholar
• Benedict LA, Kusne S, Torre-Cisneros J, Hunt SJ. Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis 1992; 15: 17–21.
   PubMedGoogle Scholar
• Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1993; 23: 577–586.
   Google Scholar
• Gallis HA, Berman RA, Cate TR, Hamilton JD, Gunnells JC, Stickel DL. Fungal infection following renal transplantation. Arch Intern Med 1975; 135: 1163–1172.
   PubMedGoogle Scholar
• Morales LA, Gonzalez ZA, Santiago-Delpin EA. Chromoblas-tomycosis in a renal transplant patient. Nephron 1985; 40: 238–240.
   Google Scholar
• Lakshmi V, Rao BN, Ratnakar KS. Phaeomycotic cyst in a post-renal transplant patient. Ind .1 Path Microbiol 1993; 36: 315–317.
   PubMedGoogle Scholar
• McCown HF, Sahn FF. Subcutaneous phaeohyphomycosis and nocardiosis in a kidney transplant patient. J Am Acad Denn 1997; 36 (5): 863–866.
   PubMedGoogle Scholar
• Jacyk WK, Du Bruyn JH, Holm N, Gryffenberg H, Karusseit VO. Cutaneous infection due to Cladophialophora bantiana in a patient receiving immunosuppressive therapy. Br J Dermatol 1997; 136: 428–430.
   PubMedGoogle Scholar
• McGinnis MR, Rinaldi MG, Winn RE. Emerging agents of phaeohyphomycosis: pathogenic species of Bipolaris and aserohilum. J Gun Microbiol 1986; 24: 250–259.
   Google Scholar
• Sudduth El, Grumbley Al III, Farra WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in hu-mans. Clin Infect Dis 1992; 15: 639–644.
   PubMed Web of Science ®Google Scholar
• Gold WL, Vellend H, Salit 1E, et al. Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis 1994; 19: 339–341.
   Google Scholar
• Collee G, Berhoef LHM, van't Wout JW, van Brummelen P, Eulderink F, Dijkmans BAC. Tenosynovitis caused by Ex-ophiala mansonii in an immunocompromised host. Arth Rheum 1988; 31 (9): 1213–1214.
   Google Scholar
• Jha V, Krishna VS, Chakrabarti A, et al. Subcutaneous phaeohyphomycosis in a renal transplant recipient: A case report and review of the literature. Am J Kid Dis 1996; 28: 137–139.
   PubMed Web of Science ®Google Scholar
• Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW. Correlation between in vitro susceptibility test- ing to itraconazole (ITR) and in vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40:401–414.
   PubMed Web of Science ®Google Scholar
• Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro—in vivo correla-tion data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235–247.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Najvar LK, Yu CY, Graybill JR. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Antimicrob Agents Chemother 1997; 41: 1120–1123.
   PubMed Web of Science ®Google Scholar
• Sugar AM. Amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother 1995; 39: 1907-1912.
   Google Scholar
• Polak A. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis, and wangiellosis in mice. Chemotherapy (Basel) 1987; 33: 381–395.
   PubMedGoogle Scholar
• Schaffner A, Bohler A. Amphotericin B refractory aspergillosis after itraconazole — evidence for significant antagonism. My-coses 1993; 36: 421–424.
   PubMed Web of Science ®Google Scholar
• Scheven M, Schwegler F. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro. Antimicrob Agents Chemother 1995; 39 (8): 1779–1783.
   PubMedGoogle Scholar
• Yu VL, Felegie TP, Yee RB, Pasculle AW, Taylor FH. Syner-gistic interaction in vitro with use of three antibiotics simulta-neously against Pseudomonas maltophilia. J Infect Dis 1980; 142: 602–607.
   Google Scholar
• Berenbaum MC, Yu VL, Felegie TP. Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother 1983; 12: 555–563.
   Google Scholar
• Odds FC. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi. An-timicrob Agents Chemother 1982; 22: 763–770.
   PubMedGoogle Scholar